St. Jude Children's Research Center

Memphis, TN
(888) 803-1766

Accepting patients

T Cells Plus Selected Use of Blinatumomab

Provision of TCRγδ T Cells and Memory T Cells Plus Selected Use of Blinatumomab in Naïve T-cell Depleted Haploidentical Donor Hematopoietic Cell Transplantation for Hematologic Malignancies Relapsed or Refractory Despite Prior Transplantation
Learn more
  • Allogeneic Stem Cell Transplant
  • Bispecific Antibody
  • Phase 2

Accepting patients

Genetics in Hematological Diseases

Investigation of the Genetics of Hematologic Diseases
Learn more
  • Genetic Sequencing
  • Patient Registry
  • Observational Trial
Get personalized results in 60 seconds
All clinical trials have eligibility criteria - or a list of reasons why you may be able or unable to participate in a trial. Answer a few questions to view your personalized results - all in under 60 seconds.
Help me find trials

Accepting patients

CPX-351 (VYXEOS)

A Prospective, Single Site, Single-Arm Pilot Study of CPX-351 (VYXEOS) in Individuals < 22 Years With Secondary Myeloid Neoplasms
Learn more
  • Allogeneic Stem Cell Transplant
  • Chemotherapy
  • Steroid
  • Phase 2

Accepting patients

SJFAMILY

Familial Investigations of Childhood Cancer Predisposition
Learn more
  • Genetic Sequencing
  • Observational Trial

Not yet accepting

IAMFIT

Intensive Tailored Exercise Training With NAD+ Precursor Supplementation to Improve Muscle Mass and Fitness in Adolescent and Young Adult Hematopoietic Cell Transplant Survivors
Learn more
  • Phase 2

Accepting patients

PedAL Screening

Pediatric Acute Leukemia (PedAL) Screening Trial - Developing New Therapies for Relapsed Leukemias
Learn more
  • Phase 1/2

Accepting patients

Imetelstat Combination Therapy

A Phase 1 Study of GRN163L (Imetelstat) in Combination With Fludarabine and Cytarabine for Patients With Acute Myeloid Leukemia That is in Second or Greater Relapse or That is Refractory to Relapse Therapy; Myelodysplastic Syndrome or Juvenile Myelomonocytic Leukemia in First or Greater Relapse or is Refractory to Relapse Therapy
Learn more
  • Telomerase Inhibitor
  • Phase 1